James Porter is President and Chief Executive Officer of Nuvalent, Inc. (NUVL). The company reported total compensation of $11,393,602 for fiscal year 2025.
| Salary | $652,100 |
|---|---|
| Bonus | $0 |
| Stock awards | $4,392,563 |
| Option awards | $5,857,906 |
| Non-equity incentive plan | $469,512 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $21,521 |
| Total | $11,393,602 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Nuvalent, Inc. filed April 28, 2026, accession 0001861560-26-000013.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| James Porter this page | President and Chief Executive Officer | $11,393,602 |
| Christopher Turner | Chief Medical Officer | $4,239,298 |
| Alexandra Balcom | Chief Financial Officer and Treasurer | $4,170,614 |
| Darlene Noci | Chief Development Officer | $4,158,140 |
| Deborah Miller | Chief Legal Officer and Secretary | $4,157,524 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Nuvalent, Inc. compensation brief.
James Porter's compensation sits inside Nuvalent, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.